ArticleHeliyon2021
CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder.
Chihiro Namatame et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ArticleHeliyon2021
Chihiro Namatame et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.